Malaghan Institute of Medical Research
Wellington, New Zealand
Download Job Adv
Full-time, fixed-term, 1-2 years
Applications close Friday 14th February 2020
The Malaghan Institute of Medical Research has recently commenced an exciting phase I clinical trial of third-generation chimeric antigen receptor (CAR) T-cells for patients with relapsed and refractory non-Hodgkin lymphoma. We are looking to appoint an experienced and driven haematology or oncology registrar as our new Clinical Research Fellow for the trial. This will be a full-time, fixed- term, 1-2 year role depending on the right applicant.
The successful Fellow will be based at the Institute, also spending time between the Wellington Blood & Cancer Centre and the Clinical Trials Unit at CCDHB. You will work with the Clinical Director, Clinical Trials Nurse, Quality Facilitator and the GMP team to gain experience in CAR T-cell manufacture, clinical trial design and conduct, CAR T-cell toxicity management and cellular therapy quality systems. This Fellowship can be combined with a post-graduate degree qualification.
Applicants must hold or be eligible for registration with the New Zealand Medical Council.
Education and experience:
For full details and to apply, please submit your CV and Cover Letter via this link:
Applications close Friday 14th February 2020 for an anticipated July start. Interviews will be held throughout should the right candidate apply.
Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114
Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.